hsa.miR.891a.5p was negatively associated with LINC02446, LINC01857, and IL7R, individually, while LINC02446 and LINC01857 were positively related to IL7R, implying that hsa.miR.891a.5p may inhibit IL7R expression and subsequently restrain tumor proliferation, whereas LINC02446 and LINC01857 may enhance IL7R abundance and thus boost cancer progression (Figure 2D). The gene discussed is IL7R; the disease is cancer.